Kate Rochlin

CIK: 0001898521

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (7.7%)

Derivative conversions

Awards (A)9 (69.2%)

Compensation grants

Other (G, F, J, C, D, …)3 (23.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INAB

IN8BIO, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

INAB
IN8BIO, INC.
May 9, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
60K shares-
INAB
IN8BIO, INC.
Feb 4, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
80K shares-
INAB
IN8BIO, INC.
Dec 22, 2025
Award(A)
Direct
7.2K shares at avg. $1.38$10K
INAB
IN8BIO, INC.
Apr 30, 2025
Exercise(M)
Direct
12.3K shares at avg. $0.18$2K
INAB
IN8BIO, INC.
Apr 27, 2025
Award(A)
Series B Warrants (right to buy)
Direct
12.3K shares-
INAB
IN8BIO, INC.
Apr 27, 2025
Disposition(D)
Series A Warrants (right to buy)
Direct
12.3K shares-
INAB
IN8BIO, INC.
Apr 27, 2025
Award(A)
Series A Warrants (right to buy)
Direct
12.3K shares-
INAB
IN8BIO, INC.
Apr 27, 2025
Disposition(D)
Series B Warrants (right to buy)
Direct
12.3K shares-
INAB
IN8BIO, INC.
Feb 5, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
339K shares-
INAB
IN8BIO, INC.
Dec 19, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
302.8K shares-
INAB
IN8BIO, INC.
Oct 4, 2024
Award(A)
Direct
25.3K shares-
INAB
IN8BIO, INC.
Oct 4, 2024
Disposition(D)
Series A Warrants (right to buy)
Direct
12.3K shares-
INAB
IN8BIO, INC.
Sep 4, 2024
Award(A)
Employee Stock Option (right to buy)
Direct
250K shares-

		Type	Shares	Price		Ownership
May 9, 2026	INAB IN8BIO, INC.	Award(A) Employee Stock Option (right to buy)	60,000	-	-	Direct
Feb 4, 2026	INAB IN8BIO, INC.	Award(A) Employee Stock Option (right to buy)	80,000	-	-	Direct
Dec 22, 2025	INAB IN8BIO, INC.	Award(A)	7,247	$1.38	$10,001	Direct
Apr 30, 2025	INAB IN8BIO, INC.	Exercise(M)	12,295	$0.18	$2,267	Direct
Apr 27, 2025	INAB IN8BIO, INC.	Award(A) Series B Warrants (right to buy)	12,295	-	-	Direct
Apr 27, 2025	INAB IN8BIO, INC.	Disposition(D) Series A Warrants (right to buy)	12,295	-	-	Direct
Apr 27, 2025	INAB IN8BIO, INC.	Award(A) Series A Warrants (right to buy)	12,295	-	-	Direct
Apr 27, 2025	INAB IN8BIO, INC.	Disposition(D) Series B Warrants (right to buy)	12,295	-	-	Direct
Feb 5, 2025	INAB IN8BIO, INC.	Award(A) Employee Stock Option (right to buy)	338,950	-	-	Direct
Dec 19, 2024	INAB IN8BIO, INC.	Award(A) Employee Stock Option (right to buy)	302,839	-	-	Direct
Oct 4, 2024	INAB IN8BIO, INC.	Award(A)	25,316	-	$0	Direct
Oct 4, 2024	INAB IN8BIO, INC.	Disposition(D) Series A Warrants (right to buy)	12,295	-	-	Direct
Sep 4, 2024	INAB IN8BIO, INC.	Award(A) Employee Stock Option (right to buy)	250,000	-	-	Direct

1-13 of 13 transactions

About Rochlin Kate

Rochlin Kate (SEC CIK 0001898521) files insider reports with the SEC as President and COO of IN8BIO, INC. (INAB).

Signal8 holds 8 ownership filings by Rochlin Kate, all Form 4s, filed between Sep 5, 2024 and May 12, 2026. Those filings report 13 transactions, from Sep 4, 2024 to May 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rochlin Kate's filings is in NEW YORK, NY.

Recent filings by Rochlin Kate

May 9, 2026: Grant or award of INAB derivative securities (Form 4, code A).
Feb 4, 2026: Grant or award of INAB derivative securities (Form 4, code A).
Dec 22, 2025: Grant or award of INAB shares (Form 4, code A).
Apr 30, 2025: Option exercise of INAB shares (Form 4, code M).
Apr 27, 2025: Grant or award of INAB derivative securities (Form 4, code A).

Other insiders filing for IN8BIO, INC. (INAB)

FAIRBAIRN EMILY, Director
Ho William Tai-Wei, CEO
Greenwood Luba, Director
Lamb Lawrence, EVP and CSO
McCall Patrick, CHIEF FINANCIAL OFFICER
Epperly Corinne, Director

How to read Form 4 transaction codes